Biotech China 2014
TRANSLATIONAL MEDICINE
The Moscone North Convention Center
747 Howard Street
San Francisco-94103, CA
www.PEGSummit.com
Molecular diagnostics

LAUNCHING SUCCESSFUL PRODUCTS IN THE
DEVELOPING WORLD

Molecular Diagnostics
Mastering Medicinal Chemistry
Pathway Analysis
Stem Cells Congress
R&D Risk Mitigation
Clinical Trials Asia
Preclinical Development
Translational Medicine
Cytokine-Based Therapeutics
Cancer Molecular Markers
Trends in Drug Safety
THE PREDOMINANT DISCOVERY, DIAGNOSTIC, AND DEVELOPMENT EVENT

Schedule of Presentations:

Tuesday, March 25, 2008
07:00:00 Registration Open
08:00:00 PLENARY KEYNOTE SESSION
Wednesday, March 26, 2008
07:00:00 Registration Open
08:00:00 PLENARY KEYNOTE SESSION
09:40:00 Grand Opening Refreshment Break in the Exhibit Hall
11:00:00 Chairperson’s Remarks Michael N. Liebman
11:05:00 Translational Medicine: What, Why and How? Michael N. Liebman
11:40:00 Impact of Translational Methods on Drug Development Richard Sachse
12:10:00 An Ontology Driven Clinical Trials Management System David Parrish
12:40:00 Technology Spotlight (Sponsorship Available)
13:10:00 Walk & Talk Luncheon in Exhibit Hall
14:15:00 Chairperson’s Remarks Sandor Szalma
14:20:00 The Winding Path(ways) to Biomarker Discovery Sandor Szalma
14:50:00 Predictive Response Biomarkers – Theory and Practice Hans Winkler
15:20:00 The Challenges of Biomarker Validation in the Clinical Setting Stephen M Hewitt
15:50:00 Expression of Genes and microRNAs as Biomarkers of Hematopoietic Stem Cell Potency David Stroncek
16:20:00 Reception in the Exhibit Hall (Sponsorship Available)
17:00:00 Break-Out Discussions in the Exhibit Hall
18:00:00 End of Day
Thursday, March 27, 2008
05:15:00 Antibody Program: From Discovery to Clinic Michael Perricone
08:25:00 Chairperson’s Remarks Sandor Szalma
08:30:00 Diagnostics in Translation: A Challenge to Value Paul R. Billings
09:00:00 Conformational Amyloid Proteins as Biomarkers for Neurodegenerative Disease K. Lenhard Rudolph
09:30:00 RNA Amplification as an Essential Approach for Biomarker Discovery Ena Wang
10:00:00 Technology Spotlight Sponsored by Debra A Hope
10:15:00 Technology Spotlight (Sponsorship Available)
10:30:00 Poster Competition & Refreshment Break in the Exhibit Hall
11:30:00 Panel Discussion
12:30:00 Presentation I: Low Abundance Tissue-Specific Circulating Biomarkers
13:00:00 Presentation II: High-Throughput Gene Expression Analysis Using-BioMark 48.48 Dynamic Arrays Sandy Spurgeon
13:30:00 Break
13:45:00 Chairperson’s Remarks Dominic Spinella
13:50:00 Challenges and Opportunities in Translational Oncology Dominic Spinella
14:20:00 Bidirectional Bedside Lab Bench Process as a Means to Optimize the Development of Innovative Immunotherapies in Cancer Adrian Bot
14:50:00 Translating Mechanistic Understanding into Clinical Utility for HDAC Inhibitors Sriram Balasubramanian
15:20:00 Plenary Keynote Speaker Ice Bound - A Doctor’s Incredible Battle for Survival at the South Pole Jerri Nielsen
16:00:00 Ice Cream Refreshment Break in the Exhibit Hall with BEST OF SHOW AWARDS
16:45:00 Molecular Predictors for the Outcome of Bladder Cancer: A Multi-center Validation Study of 400 Patients Torben F Orntoft
18:00:00 End of Session
Friday, March 28, 2008
08:30:00 Chairperson’s Remarks
08:35:00 How Do in Vitro Preclinical Results Translate into in Vivo Models: What Do We Lose or Gain in Translation to Patients?
09:05:00 Optimizing Preclinical Assessment and Decision-Making Steve Linder
09:50:00 Questions and Answers
10:05:00 Technology Spotlight (Sponsorship Available)
10:20:00 Coffee Break in the Foyer
11:00:00 To be Announced
11:30:00 Assessment of CNS Penetration: Preclinical-Clinical Correlations and Relationships between Protein Binding, CSF Distribution, and Target Receptor Occupancy
12:00:00 Luncheon Workshop (Sponsorship Available) or Lunch on Your Own CHOOSING AN IMAGING MODALITY FOR BOTH INTERNAL DECISION MAKING AND REGULATORY APPROVAL
13:00:00 Chairperson’s Remarks Kohkan Shamsi
13:05:00 Imaging Biomarkers in Early Clinical Development of Novel Therapeutic Agents Jeffrey Evelhoch
13:35:00 Imaging in Phase II/III Clinical Development Haren Rupani
14:05:00 Imaging as a Biomarker in Oncology Drug Trials and Improving Cancer Patient Care Gary J. Kelloff
14:35:00 The Promises and Realities of Imaging as a Translational Biomarker in Drug Development Tim Mccarthy
15:05:00 Close of Conference
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.